Alive HealthTech Growth Fund | Activity | F4

F4/Alive HealthTech Growth Fund/Activity

Alive HealthTech Growth Fund Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Investment

ALIVE led UltraSight's $24M Series B2 financing, the first investment from newly launched ALIVE Growth Fund III.

UltraSight

UltraSight Alive HealthTech Growth Fund

einnews.comSEP 23, 2026

SEP 23, 2026

New Fund

Announced the initial closing of ALIVE Growth Fund III, a $180-200M growth-stage HealthTech fund.

ALIVE Growth Fund III

Alive HealthTech Growth Fund

calcalistech.comNOV 19, 2025

NOV 19, 2025

Milestone

Portfolio company Navina was ranked among the Top 5 Best Startups to Work For by Dun's 100.

Navina

Navina Alive HealthTech Growth Fund

linkedin.comNOV 1, 2025

NOV 1, 2025

Exit

Portfolio company Wisdo Health was acquired by Talkspace to expand peer-support mental health services.

Wisdo

Wisdo Alive HealthTech Growth Fund

fiercehealthcare.comOCT 6, 2025

OCT 6, 2025

Exit

Portfolio company Cynerio, a healthcare cybersecurity platform, was acquired by Axonius in a transaction valued at over $100M.

Cynerio

Cynerio Alive HealthTech Growth Fund

mddionline.comJUL 29, 2025

JUL 29, 2025

News

Portfolio company OncoHost received the Gold Award at the 2025 Merit Awards for Business in Research & Development.

OncoHost

OncoHost Alive HealthTech Growth Fund

oncohost.comJUL 9, 2025

JUL 9, 2025

News

Portfolio company OncoHost was named "Proteomics Innovation of the Year" at the 2025 BioTech Breakthrough Awards.

OncoHost

OncoHost Alive HealthTech Growth Fund

oncohost.comJUN 11, 2025

JUN 11, 2025

3 investments· JUL 2024 – MAR 2025Show all

Investment

Navina closed a $55M Series C led by Goldman Sachs Alternatives, with existing investor Alive participating.

Navina

Navina Alive HealthTech Growth Fund

navina.aiMAR 25, 2025

MAR 25, 2025

Investment

Wisdo Health completed a $5M Series A extension, bringing total Series A funding to $11M.

Wisdo

Wisdo Alive HealthTech Growth Fund

tracxn.comJAN 6, 2025

JAN 6, 2025

Investment

Magenta Medical closed a $105M financing round led by Novo Holdings to advance its heart pump clinical program.

Magenta Medical

Magenta Medical Alive HealthTech Growth Fund

prnewswire.comJUL 23, 2024

JUL 23, 2024

Exit

Alive's first portfolio exit: Innovalve, a transcatheter mitral valve replacement developer, was acquired by Edwards Lifesciences for approximately $350M.

Innovalve

Innovalve Alive HealthTech Growth Fund

ir.edwards.comJUL 15, 2024

ice.co.il

JUL 15, 2024

3 investments· MAY 2021 – MAY 2023Show all

Investment

Magenta Medical raised $55M led by OrbiMed to support late-stage clinical development of its heart pump technology.

Magenta Medical

Magenta Medical Alive HealthTech Growth Fund

prnewswire.comMAY 3, 2023

MAY 3, 2023

Investment

ALIVE led OncoHost's $35M Series C to expand clinical trials and prepare for US commercialization of its proteomics platform.

OncoHost

OncoHost Alive HealthTech Growth Fund

oncohost.comMAY 10, 2022

MAY 10, 2022

Investment

ALIVE led Cynerio's $30M Series B to scale its healthcare cybersecurity platform.

Cynerio

Cynerio Alive HealthTech Growth Fund

en.globes.co.ilMAY 19, 2021

MAY 19, 2021

Page 1 of 2